These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 11499346)
1. Prognostic factors in stage I ovarian carcinoma. Vergote I Verh K Acad Geneeskd Belg; 2001; 63(3):257-71; discussion 272-6. PubMed ID: 11499346 [TBL] [Abstract][Full Text] [Related]
2. Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Vergote I; De Brabanter J; Fyles A; Bertelsen K; Einhorn N; Sevelda P; Gore ME; Kaern J; Verrelst H; Sjövall K; Timmerman D; Vandewalle J; Van Gramberen M; Tropé CG Lancet; 2001 Jan; 357(9251):176-82. PubMed ID: 11213094 [TBL] [Abstract][Full Text] [Related]
3. Prognostic importance of intraoperative rupture of malignant ovarian epithelial neoplasms. Sainz de la Cuesta R; Goff BA; Fuller AF; Nikrui N; Eichhorn JH; Rice LW Obstet Gynecol; 1994 Jul; 84(1):1-7. PubMed ID: 8008300 [TBL] [Abstract][Full Text] [Related]
4. [Assessment of prognostic factors in common ovarian tumors of varying malignancy]. Demeter A; Várkonyi T; Csapó Z; Szánthó A; Oláh J; Papp Z Magy Onkol; 2004; 48(3):259-65. PubMed ID: 15520877 [TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study. Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC; Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296 [TBL] [Abstract][Full Text] [Related]
6. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma. Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146 [TBL] [Abstract][Full Text] [Related]
7. Clinical value of morphometric and DNA flow cytometric variables as independent predictors of survival in epithelial ovarian carcinoma: a 5-year follow-up study. Veerman MM; van der Wurff AA; van de Water M; Kruitwagen RF; Feijen HW; Vos MC Int J Gynecol Pathol; 2009 Sep; 28(5):432-41. PubMed ID: 19696612 [TBL] [Abstract][Full Text] [Related]
8. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis. Sherman ME; Mink PJ; Curtis R; Cote TR; Brooks S; Hartge P; Devesa S Cancer; 2004 Mar; 100(5):1045-52. PubMed ID: 14983501 [TBL] [Abstract][Full Text] [Related]
9. [Prognostic factors of common epithelial ovarian cancer treated by surgery and cisplatin based combination chemotherapy]. Sasaki H; Ochiai K; Terashima Y; Mochizuki S; Soda T; Nishimura H; Yakushiji M; Hirabayashi M Gan No Rinsho; 1989 Oct; 35(13):1615-20. PubMed ID: 2585733 [TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in patients with stage I epithelial ovarian cancer. Dembo AJ; Davy M; Stenwig AE; Berle EJ; Bush RS; Kjorstad K Obstet Gynecol; 1990 Feb; 75(2):263-73. PubMed ID: 2300355 [TBL] [Abstract][Full Text] [Related]
11. [Laparoscopic preliminary surgery of ovarian malignancies. Experiences from 127 German gynecologic clinics]. Kindermann G; Maassen V; Kuhn W Geburtshilfe Frauenheilkd; 1995 Dec; 55(12):687-94. PubMed ID: 8582588 [TBL] [Abstract][Full Text] [Related]
12. [Analysis of risk factors for epithelial ovarian cancer recurrence]. Liu S; Liu JH; Huang H; Peng XP; Wang YM Ai Zheng; 2003 Nov; 22(11):1197-200. PubMed ID: 14613652 [TBL] [Abstract][Full Text] [Related]
13. Prognostic importance of preoperative CA-125 in International Federation of Gynecology and Obstetrics stage I epithelial ovarian cancer: an Australian multicenter study. Paramasivam S; Tripcony L; Crandon A; Quinn M; Hammond I; Marsden D; Proietto A; Davy M; Carter J; Nicklin J; Perrin L; Obermair A J Clin Oncol; 2005 Sep; 23(25):5938-42. PubMed ID: 16087942 [TBL] [Abstract][Full Text] [Related]
14. Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma. Engelen MJ; Kos HE; Willemse PH; Aalders JG; de Vries EG; Schaapveld M; Otter R; van der Zee AG Cancer; 2006 Feb; 106(3):589-98. PubMed ID: 16369985 [TBL] [Abstract][Full Text] [Related]
15. Management and outcome of recurrent well-differentiated thyroid carcinoma. Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757 [TBL] [Abstract][Full Text] [Related]
16. [Prognostic factors in patients with stage I epithelial ovarian cancer]. Wen HW; Liu SW Zhonghua Fu Chan Ke Za Zhi; 1994 Apr; 29(4):235-7, 255. PubMed ID: 8082450 [TBL] [Abstract][Full Text] [Related]
17. Quantitative prognostic features in FIGO I ovarian cancer patients without postoperative treatment. Brugghe J; Baak JP; Wiltshaw E; Brinkhuis M; Meijer GA; Fisher C Gynecol Oncol; 1998 Jan; 68(1):47-53. PubMed ID: 9454660 [TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the prognostic factors in patients with stage-I and -II ovarian cancer treated by an operation + irradiation variant]. Tarlowska L; Czesnin K; Psikuta M; Romejko M Vopr Onkol; 1986; 32(3):36-44. PubMed ID: 3962255 [TBL] [Abstract][Full Text] [Related]
20. [Prognostic factors of epithelial ovarian cancer in young women]. Zhang R; Wu LY; Zhang WH; Li HJ; Li SM; Liu LY Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):264-7. PubMed ID: 12839691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]